[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [Arvinas, Inc](/topic/$arvn) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Lifesci Where Does the Landscape for Advanced/Metastatic ER+ Breast Cancer Stand After Roches evERA Data at ESMO Full report in Telegram (in bio)👆 $RHHBY $AZN $NVS $PFE $LLY $GILD $ARVN $OLMA $DSNKY $TMO $ILMN $TXG $PACB $EXEL $KPTI $IMCR $ABCL $SWTX $RNA $ARCT $RCUS $MRSN" [X Link](https://x.com/Biobeats99/status/1979844131401924939) [@Biobeats99](/creator/x/Biobeats99) 2025-10-19T09:36Z XXX followers, XXX engagements "@BianchiniGP @myESMO just like the rest of the serds and degraders $arvn $olma $lly $rhhby $azn" [X Link](https://x.com/financebully/status/1979642722911936874) [@financebully](/creator/x/financebully) 2025-10-18T20:16Z XXX followers, XXX engagements "@seedy19tron @Andre_AGTC @WallStSai don't short $celc brian sullivan. ;) roche data is bs - mutESR1 population is likely driving the benefit in the itt group. after $arvn data i don't see any serd winning in itt including $olma unless they fudge data by more favorable pt population" [X Link](https://x.com/financebully/status/1979577507788841389) [@financebully](/creator/x/financebully) 2025-10-18T15:57Z XXX followers, XXX engagements "Roche pill delays tumor progression in closely watched breast cancer study @ByJonGardner $RHHBY $LLY $ARVN #ESMO25" [X Link](https://x.com/BentheFidler/status/1979537545487958161) [@BentheFidler](/creator/x/BentheFidler) 2025-10-18T13:18Z 8333 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Lifesci Where Does the Landscape for Advanced/Metastatic ER+ Breast Cancer Stand After Roches evERA Data at ESMO Full report in Telegram (in bio)👆 $RHHBY $AZN $NVS $PFE $LLY $GILD $ARVN $OLMA $DSNKY $TMO $ILMN $TXG $PACB $EXEL $KPTI $IMCR $ABCL $SWTX $RNA $ARCT $RCUS $MRSN"
X Link @Biobeats99 2025-10-19T09:36Z XXX followers, XXX engagements
"@BianchiniGP @myESMO just like the rest of the serds and degraders $arvn $olma $lly $rhhby $azn"
X Link @financebully 2025-10-18T20:16Z XXX followers, XXX engagements
"@seedy19tron @Andre_AGTC @WallStSai don't short $celc brian sullivan. ;) roche data is bs - mutESR1 population is likely driving the benefit in the itt group. after $arvn data i don't see any serd winning in itt including $olma unless they fudge data by more favorable pt population"
X Link @financebully 2025-10-18T15:57Z XXX followers, XXX engagements
"Roche pill delays tumor progression in closely watched breast cancer study @ByJonGardner $RHHBY $LLY $ARVN #ESMO25"
X Link @BentheFidler 2025-10-18T13:18Z 8333 followers, XXX engagements
/topic/$arvn/posts